KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Davita (DVA) EBT (2016 - 2025)

Davita (DVA) has disclosed EBT for 17 consecutive years, with $382.8 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT fell 7.49% to $382.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 billion, a 11.99% decrease, with the full-year FY2025 number at $1.3 billion, down 11.99% from a year prior.
  • EBT was $382.8 million for Q4 2025 at Davita, up from $308.8 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $432.3 million in Q2 2021 to a low of $147.5 million in Q4 2022.
  • A 5-year average of $327.0 million and a median of $358.9 million in 2022 define the central range for EBT.
  • Peak YoY movement for EBT: plummeted 53.17% in 2022, then soared 95.99% in 2023.
  • Davita's EBT stood at $314.9 million in 2021, then plummeted by 53.17% to $147.5 million in 2022, then surged by 95.99% to $289.1 million in 2023, then soared by 43.13% to $413.7 million in 2024, then decreased by 7.49% to $382.8 million in 2025.
  • Per Business Quant, the three most recent readings for DVA's EBT are $382.8 million (Q4 2025), $308.8 million (Q3 2025), and $368.9 million (Q2 2025).